155 related articles for article (PubMed ID: 6448578)
1. In vitro evaluation of cefoperazone.
Hinkle AM; LeBlanc BM; Bodey GP
Antimicrob Agents Chemother; 1980 Mar; 17(3):423-7. PubMed ID: 6448578
[TBL] [Abstract][Full Text] [Related]
2. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Lang SD; Edwards DJ; Durack DT
Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
[TBL] [Abstract][Full Text] [Related]
4. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Magnussen CR; Sammartino MT; Ernest KD
Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
[TBL] [Abstract][Full Text] [Related]
5. The comparative in vitro susceptibility of cefazolin-resistant organisms to six cephalosporins, four penicillins, and three aminoglycosides.
Chan EL; Birk RJ; Zabransky RJ
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):525-33. PubMed ID: 3851708
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
Auckenthaler R; Waldvogel FA
Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Reimer LG; Mirrett S; Reller LB
Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
[TBL] [Abstract][Full Text] [Related]
9. Mezlocillin: in vitro studies of a new broad-spectrum penicillin.
Bodey GP; Pan T
Antimicrob Agents Chemother; 1977 Jan; 11(1):74-9. PubMed ID: 836016
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.
Matsubara N; Minami S; Muraoka T; Saikawa I; Mitsuhashi S
Antimicrob Agents Chemother; 1979 Dec; 16(6):731-5. PubMed ID: 316988
[TBL] [Abstract][Full Text] [Related]
11. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro study of temocillin (BRL 17421), a new penicillin.
Bolivar R; Weaver SS; Bodey GP
Antimicrob Agents Chemother; 1982 Apr; 21(4):641-5. PubMed ID: 6919412
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
Tarpay MM; Welch DF; Marks MI
Chemotherapy; 1982; 28(4):261-6. PubMed ID: 6214382
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin.
Welch DF; Matsen JM
Clin Ther; 1980; 3(Spec Issue):127-9. PubMed ID: 6446385
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
Eickhoff TC; Ehret J
Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of LY127935.
Fass RJ
Antimicrob Agents Chemother; 1979 Oct; 16(4):503-9. PubMed ID: 518080
[TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial activity of cefpirome, a new cephalosporin with a broad antimicrobial spectrum.
Arai S; Kobayashi S; Hayashi S; Fujimoto K
Jpn J Antibiot; 1987 May; 40(5):969-82. PubMed ID: 3669290
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1982 Jan; 21(1):11-8. PubMed ID: 6805421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
